Your browser doesn't support javascript.
loading
Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease.
Kinsella, Francesca A M; Inman, Charlotte F; Gudger, Amy; Chan, Yuen T; Murray, Duncan J; Zuo, Jianmin; McIlroy, Graham; Nagra, Sandeep; Nunnick, Jane; Holder, Kathy; Wall, Kerry; Griffiths, Mike; Craddock, Charles; Nikolousis, Emmanouil; Moss, Paul; Malladi, Ram.
Afiliación
  • Kinsella FAM; School of Cancer Sciences, University of Birmingham, Birmingham, UK; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK.
  • Inman CF; School of Cancer Sciences, University of Birmingham, Birmingham, UK.
  • Gudger A; Heartlands Hospital, Heart of England NHS Foundation trust, Birmingham, UK.
  • Chan YT; School of Cancer Sciences, University of Birmingham, Birmingham, UK.
  • Murray DJ; School of Cancer Sciences, University of Birmingham, Birmingham, UK.
  • Zuo J; School of Cancer Sciences, University of Birmingham, Birmingham, UK.
  • McIlroy G; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK.
  • Nagra S; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK.
  • Nunnick J; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK.
  • Holder K; Heartlands Hospital, Heart of England NHS Foundation trust, Birmingham, UK.
  • Wall K; West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK.
  • Griffiths M; School of Cancer Sciences, University of Birmingham, Birmingham, UK; West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK.
  • Craddock C; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK.
  • Nikolousis E; Heartlands Hospital, Heart of England NHS Foundation trust, Birmingham, UK.
  • Moss P; School of Cancer Sciences, University of Birmingham, Birmingham, UK; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK. Electronic address: p.moss@bham.ac.uk.
  • Malladi R; School of Cancer Sciences, University of Birmingham, Birmingham, UK; Centre for Clinical Haematology, Queen Elizabeth NHS Foundation Trust, Birmingham, UK.
Leuk Res ; 83: 106173, 2019 08.
Article en En | MEDLINE | ID: mdl-31276965
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Linfocitos T / Leucemia Mieloide Aguda / Quimera por Trasplante / Trasplante de Células Madre Hematopoyéticas / Linfoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Linfocitos T / Leucemia Mieloide Aguda / Quimera por Trasplante / Trasplante de Células Madre Hematopoyéticas / Linfoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido